A core outcome set for clinical trials in acute diarrhoea

被引:35
|
作者
Karas, Jacek [1 ]
Ashkenazi, Shai [2 ,3 ]
Guarino, Alfredo [4 ]
Lo Vecchio, Andrea [4 ]
Shamir, Raanan [5 ,6 ]
Vandenplas, Yvan [7 ]
Szajewska, Hania [1 ]
机构
[1] Med Univ Warsaw, Dept Paediat, PL-01184 Warsaw, Poland
[2] Schneider Childrens Med Ctr, Petah Tiqwa, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, IL-69978 Tel Aviv, Israel
[4] Univ Naples Federico II, Sect Pediat, Dept Translat Med Sci, Naples, Italy
[5] Schneider Childrens Med Ctr, Inst Gatroenterol Nutr & Liver Dis, Petah Tiqwa, Israel
[6] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[7] Vrije Univ Brussel, UZ Brussel, Dept Pediat, Brussels, Belgium
关键词
D O I
10.1136/archdischild-2014-307403
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective Core outcome sets are the baseline for what should be measured in clinical research and, thus, should serve as a guide for what should be collected and reported. The Consensus Group on Outcome Measures Made in Pediatric Enteral Nutrition Clinical Trials, established in 2012, agreed that consensus on a core set of outcomes with agreed-upon definitions that should be measured and reported in clinical trials was needed. To achieve this goal, six working groups (WGs) were setup, including WG on acute diarrhoea, whose main goal was to develop a core outcome set for trials in acute diarrhoea. Methods The first step identified how published outcomes related to acute diarrhoea were reported. The second focused on the methodology for determining which outcomes to measure in clinical trials. The third employed a two-phase questionnaire study using the Delphi technique to define clinically important outcomes to clinicians and parents. Results For therapeutic studies, the five most important outcome measures were diarrhoea duration, degree of dehydration, need for hospitalisation (or duration of hospitalisation for inpatients), the proportion of patients recovered by 48 h and adverse effects. The prophylactic core outcome set included prevention of diarrhoea, prevention of dehydration, prevention of hospitalisation and adverse effects. Conclusions The outcome sets for therapy and prevention can be recommended for use in future trials of patients with gastroenteritis. Their envisioned goal is to decrease study heterogeneity and to ease the comparability of studies. WG's next step is to determine how to measure the outcomes included in the core set.
引用
收藏
页码:359 / U79
页数:5
相关论文
共 50 条
  • [1] Developing a core outcome measurement set for clinical trials in acute diarrhoea
    Karas, Jacek
    Ashkenazi, Shai
    Guarino, Alfredo
    Lo Vecchio, Andrea
    Shamir, Raanan
    Vandenplas, Yvan
    Szajewska, Hania
    [J]. ACTA PAEDIATRICA, 2016, 105 (04) : E176 - E180
  • [2] Development of a Core Outcome Set for Clinical Trials in Melasma
    Dirr, McKenzie A.
    Christensen, Rachel E.
    Anvery, Noor
    Hisham, Farhana Ikmal
    Yi, Michael D.
    Nadir, Umer
    Dave, Loma
    Kang, Bianca Y.
    Alam, Murad
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB36 - AB36
  • [3] Core Outcome Set for Actinic Keratosis Clinical Trials
    Reynolds, Kelly A.
    Schlessinger, Daniel I.
    Vasic, Jelena
    Iyengar, Sanjana
    Qaseem, Yaqoob
    Behshad, Ramona
    DeHoratius, Danielle M.
    Denes, Pablo
    Drucker, Aaron M.
    Dzubow, Leonard M.
    Etzkorn, Jeremy R.
    Harwood, Catherine
    Kim, John Y. S.
    Lee, Erica H.
    Lissner, Gary S.
    Marghoob, Ashfaq A.
    Matin, Rubeta N.
    Mattox, Adam
    Mittal, Bharat B.
    Thomas, J. Regan
    Zhou, Xiaolong Alan
    Zloty, David
    Schmitt, Jochen
    Kirkham, Jamie
    Poon, Emily
    Sobanko, Joseph F.
    Cartee, Todd V.
    Maher, Ian A.
    Alam, Murad
    [J]. JAMA DERMATOLOGY, 2020, 156 (03) : 326 - 333
  • [4] DEVELOPMENT OF A CORE OUTCOME SET FOR CLINICAL TRIALS IN CHILDHOOD CONSTIPATION
    Steutel, Nina
    Kuizenga-Wessel, Sophie
    Benninga, Marc A.
    Devreker, Tierry
    Scarpato, Elena
    Staiano, Annamaria
    Szajewska, Hania
    Vandenplas, Yvan
    Tabbers, Merit
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S750 - S751
  • [5] A global core outcome measurement set for snakebite clinical trials
    Abouyannis, Michael
    Esmail, Hanif
    Hamaluba, Mainga
    Ngama, Mwanajuma
    Mwangudzah, Hope
    Mumba, Noni
    Yeri, Betty K.
    Mwalukore, Salim
    Alphan, Hassan J.
    Aggarwal, Dinesh
    Alcoba, Gabriel
    Cammack, Nick
    Chippaux, Jean-Philippe
    Coldiron, Matthew E.
    Gutierrez, Jose M.
    Habib, Abdulrazaq G.
    Harrison, Robert A.
    Isbister, Geoffrey K.
    Lavonas, Eric J.
    Martins, Diogo
    Ribeiro, Isabela
    Watson, James A.
    Williams, David J.
    Casewell, Nicholas R.
    Walker, Sarah A.
    Lalloo, David G.
    [J]. LANCET GLOBAL HEALTH, 2023, 11 (02): : E296 - E300
  • [6] Protocol for development of a core outcome set for clinical trials in melasma
    Ibrahim, Sarah A.
    Kang, Bianca Y.
    Schlessinger, Daniel, I
    Chiren, Sarah G.
    Tang, Jennifer C.
    Kirkham, Jamie J.
    Schmitt, Jochen
    Poon, Emily
    Maher, Ian A.
    Sobanko, Joseph F.
    Cartee, Todd, V
    Alam, Murad
    [J]. BMJ OPEN, 2022, 12 (02):
  • [7] The HOME Core outcome set for clinical trials of atopic dermatitis
    Williams, Hywel C.
    Schmitt, Jochen
    Thomas, Kim S.
    Spuls, Phyllis, I
    Simpson, Eric L.
    Apfelbacher, Christian J.
    Chalmers, Joanne R.
    Furue, Masutaka
    Katoh, Norito
    Gerbens, Louise A. A.
    Leshem, Yael A.
    Howells, Laura
    Singh, Jasvinder A.
    Boers, Maarten
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (06) : 1899 - 1911
  • [8] Development of a Core Outcome Set for Trigeminal Neuralgia for use in clinical trials
    Nova, Carolina Venda
    Baker, Sarah
    Riordain, Richeal
    Zakrzewska, Joanna
    [J]. CEPHALALGIA, 2023, 43 (1supp) : 316 - 317
  • [9] Developing a Core Outcome Set for Clinical Trials of Chinese Medicine for Hyperlipidemia
    Li, Geng
    Han, Ruxue
    Lin, Mingjun
    Wen, Zehuai
    Chen, Xiankun
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [10] Postinflammatory hyperpigmentation: protocol for development of a core outcome set for clinical trials
    Bianca Y. Kang
    Sarah A. Ibrahim
    Divya Shokeen
    Daniel I. Schlessinger
    Jamie J. Kirkham
    Jochen Schmitt
    Emily Poon
    Ian A. Maher
    Joseph F. Sobanko
    Todd V. Cartee
    Murad Alam
    [J]. Archives of Dermatological Research, 2022, 314 : 357 - 361